2-(3-(Difluoromethyl)-5-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 100mg

3-CYANO-6-CYCLOHEXYLOXYPYRIDINE, 97.0%, 1g

2-Amino-3-(3-bromo-4-hydroxyphenyl)propanoic acid, 95.0%, 5g

5-(3-Nitro-phenyl)-[1,3,4]thiadiazol-2-ylamine, 95.0%, 1g

(S)-tert-Butyl 2-(hydroxymethyl)-2,5-dihydro-1H-pyrrole-1-carboxylate, 97%, 5g

Mubritinib, 99%, 50mg

Tris(2,2,2-trifluoroethyl) Borate>95.0%(T)1g

(R)-1-(3-(1-Aminoethyl)-2-fluorophenyl)-1,1-difluoro-2-methylpropan-2-ol hydrochloride, 98%, 250mg

2',5'-Dimethylacetophenone>98.0%(GC)25mL

(3-(2-Fluorophenyl)isoxazol-5-yl)methanol, 95.0%, 100mg

3-{[1,1'-biphenyl]-4-yl}-4,5-dihydro-1,2-oxazole-5-carboxylic acid, 95.0%, 1g

Safranina O (CI 50240), 25 g

4-Amino-5-methylpyridin-2-ol, 95.0%, 250g